The research uncovers key genetic mutations that affect cancer treatment responses and develops a predictive tool for ...

A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Belvidere-based Edible Garden is bringing something new to the table. After a successful pilot production, the hydroponic ...

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Medical experts discuss approaches to patient education on managing potential adverse events associated with adagrasib and other KRAS-targeted therapies.

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.